We are live on ! Find out more
Kovitz Investment Group Partners

Kovitz Investment Group Partners Portfolio holdings

AUM $4.31B
1-Year Est. Return 20.41%
This Fund
S&P 500
This Quarter Est. Return
-2.34%
1 Year Est. Return
+20.41%
3 Year Est. Return
+68.31%
5 Year Est. Return
+76.52%
10 Year Est. Return
+697%
AUM
$19.9B
AUM Growth
-$472M
Cap. Flow
+$70.4M
Cap. Flow %
0.35%
Top 10 Hldgs %
22.2%
Holding
1,329
New
104
Increased
512
Reduced
579
Closed
86

Sector Composition

Rank Sector Weight
1 Technology 17.72%
2 Financials 13.02%
3 Healthcare 7.17%
4 Industrials 6.79%
5 Consumer Discretionary 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAN icon
1201
Banco Santander
SAN
$210B
$133K ﹤0.01%
19,869
-509
-2% -$2.98K
DNP icon
1202
DNP Select Income Fund
DNP
$4.09B
$132K ﹤0.01%
+13,375
New +$126K
DERM icon
1203
Journey Medical
DERM
$177M
$128K ﹤0.01%
21,710
-3,000
-12% -$14.8K
COMP icon
1204
Compass
COMP
$9.66B
$126K ﹤0.01%
+14,438
New +$114K
NEWT icon
1205
NewtekOne
NEWT
$391M
$126K ﹤0.01%
10,527
+161
+2% +$2.03K
CCC
1206
CCC Intelligent Solutions
CCC
$4.08B
$124K ﹤0.01%
+13,718
New +$142K
HLLY icon
1207
Holley
HLLY
$384M
$123K ﹤0.01%
+48,017
New +$135K
DPG
1208
Duff & Phelps Utility and Infrastructure Fund
DPG
$524M
$122K ﹤0.01%
+10,000
New +$118K
QS icon
1209
QuantumScape Corp
QS
$3.74B
$117K ﹤0.01%
+28,103
New +$139K
TNONW icon
1210
Tenon Medical Inc Warrant
TNONW
$104K ﹤0.01%
5,051,000
-80,000
-2% -$1.64K
LUMN icon
1211
Lumen
LUMN
$6.44B
$99.9K ﹤0.01%
25,480
-1,305
-5% -$6.5K
MFG icon
1212
Mizuho Financial
MFG
$130B
$95.9K ﹤0.01%
17,403
+1,499
+9% +$8.24K
ASPN icon
1213
Aspen Aerogels
ASPN
$518M
$93K ﹤0.01%
14,548
-19,692
-58% -$190K
GANX icon
1214
Gain Therapeutics
GANX
$77.6M
$90.9K ﹤0.01%
+47,578
New +$106K
AMGN icon
1215
PUT
Amgen
AMGN
$222B
$90.8K ﹤0.01%
13,600
TLSA icon
1216
Tiziana Life Sciences
TLSA
$127M
$85.7K ﹤0.01%
79,365
AEG icon
1217
Aegon
AEG
$14.1B
$84.3K ﹤0.01%
12,797
+5
+0% +$32
BFLY icon
1218
Butterfly Network
BFLY
$2.35B
$82.7K ﹤0.01%
36,250
+300
+0.8% +$1.07K
OXLC
1219
Oxford Lane Capital
OXLC
$898M
$79.7K ﹤0.01%
3,375
+23
+0.7% +$572
NVRI icon
1220
Enviri
NVRI
$620M
$77.6K ﹤0.01%
+11,665
New +$91.7K
LYG icon
1221
Lloyds Banking Group
LYG
$91.3B
$75K ﹤0.01%
19,631
+1,682
+9% +$5.56K
SVRA icon
1222
Savara
SVRA
$1.19B
$69.8K ﹤0.01%
25,214
CLSK icon
1223
CleanSpark
CLSK
$3.16B
$69.6K ﹤0.01%
10,357
-222,672
-96% -$2.11M
JEQ
1224
DELISTED
abrdn Japan Equity Fund
JEQ
$68.4K ﹤0.01%
10,515
+49
+0.5% +$294
JBIO
1225
Jade Biosciences
JBIO
$1.34B
$66.5K ﹤0.01%
+758
New +$66.6K

Similar funds

Kovitz Investment Group Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Kovitz Investment Group Partners held 1,329 positions worth $19.9B, down 2.3% from $20.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Kovitz Investment Group Partners's Q1 2025 filing shows 104 new, 512 increased, 579 reduced and 86 closed positions. Its largest new stake was iShares MSCI United Kingdom ETF: 407,760 shares worth $15.3M. The largest sale was JPMorgan Chase, an estimated $81M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Kovitz Investment Group Partners's largest Q1 2025 buy was iShares MSCI United Kingdom ETF: 407,760 shares worth $15.3M.
  • Kovitz Investment Group Partners added most to Lam Research in Q1 2025, an estimated $172M increase.
  • Kovitz Investment Group Partners's biggest Q1 2025 reduction was JPMorgan Chase, cutting an estimated $81M.
  • Kovitz Investment Group Partners fully exited Vanguard Long-Term Treasury ETF in Q1 2025, selling an estimated $13.6M.
  • Kovitz Investment Group Partners's ten largest holdings make up 22% of its $19.9B portfolio in Q1 2025.
  • Kovitz Investment Group Partners opened 104 new positions and closed 86 in Q1 2025.
  • Kovitz Investment Group Partners's portfolio value fell 2.3% quarter-over-quarter to $19.9B.

Based on Kovitz Investment Group Partners's 13F filing for Q1 2025, filed 13 May 2025.